MYnd Analytics and Emmaus Life Sciences Announce Merger and Spin-off Transaction
07 janv. 2019 07h30 HE
|
MYnd Analytics, Inc.
Emmaus’ commercial lead product Endari™ (L-glutamine oral powder) is FDA approved to reduce the acute complications of sickle cell disease Endari addresses a $3 billion worldwide market MISSION...
MYnd Analytics Appoints Senior Industry Executive Patrick Herguth as Chief Executive Officer and Board Member; George Carpenter Assumes New Role as Chief Innovation Officer
12 déc. 2018 07h30 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination...
MYnd Analytics Awarded Subcontract to Support Suicide Prevention for the U.S. Department of Health and Human Services
27 nov. 2018 08h00 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics’ PEER Report Featured on CBS New York
05 nov. 2018 08h00 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics Announces Insider Buying Through Private Placement
26 sept. 2018 10h39 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics to Provide TeleEAP Services for Integrated Behavioral Health, a National Managed Behavioral Health Company
20 sept. 2018 08h00 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics Announces Nationwide Expansion of Telepsychiatry & Telebehavioral Health Services for Leading EAP Provider Claremont Behavioral Services
17 sept. 2018 12h58 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
FDA Designates Breakthrough Device Status for MYnd Analytics’ PEER 4.0
17 sept. 2018 08h43 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics Partners with Sanford Health to Provide Telepsychiatry Services Supporting Outpatient Primary Care Practices
13 sept. 2018 10h41 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics and Arcadian Telepsychiatry Services Announce Launch of Correctional Facilities Telepsychiatry Program; Designed to Provide Inmates Improved Access to Mental Health Services
11 sept. 2018 10h00 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...